Browse
Browse and Search
Search
Explore more content
12885_2021_8048_MOESM1_ESM.
docx
(17.45 kB)
File info
This item contains files with download restrictions
Fullscreen
Additional file 1 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study
Cite
Download
(17.45 kB)
Share
Embed
journal contribution
posted on 2021-04-02, 03:54
authored by
Kazutaka Hosoya
,
Daichi Fujimoto
,
Takeshi Morimoto
,
Toru Kumagai
,
Akihiro Tamiya
,
Yoshihiko Taniguchi
,
Toshihide Yokoyama
,
Tadashi Ishida
,
Hirotaka Matsumoto
,
Katsuya Hirano
,
Ryota Kominami
,
Keisuke Tomii
,
Hidekazu Suzuki
,
Tomonori Hirashima
,
Satoshi Tanaka
,
Junji Uchida
,
Mitsunori Morita
,
Masaki Kanazu
,
Masahide Mori
,
Kenji Nagata
,
Ikue Fukuda
,
Motohiro Tamiya
Additional file 1.
History
Usage metrics
Categories
Medicine
Genetics
Ecology
Immunology
Biological Sciences not elsewhere classified
Mathematical Sciences not elsewhere classified
Developmental Biology
Cancer
Mental Health
Keywords
Non-small cell lung cancer
Immunotherapy
Pembrolizumab
Acquired resistance
Oligoprogression
Licence
CC BY + CC0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC